
China.com May 20th According to the Chinese Embassy in South Korea, according to the latest domestic requirements, starting from May 20, 2022, the testing and application of health code standards for personnel taking regular flights, temporary flights, various charter flights (including "fast channel" charter flights, etc.) from South Korea to China will be cancelled nucleic acid pre-test and self-health monitoring 7 days before boarding. Regardless of the vaccination of new crown vaccine, serum antibody IgM and N protein IgM antibody testing will no longer be required.
In addition, the original "double test" was reduced to 1 nucleic acid test within 48 hours before boarding, and the blue health code was applied for a negative result. Personnel with a history of previous infection must undergo two recovery confirmation nucleic acid tests at the designated testing agency (the interval between the two times is more than 24 hours). Other requirements are the same as ordinary passengers. The login crew inspection requires the same as ordinary passengers and no longer require 14 days of health monitoring. After the implementation of the new regulations of
, the entire process of general passengers is: ① nucleic acid test within 48 hours before boarding → ② Apply for a blue code based on negative results and relevant identity materials → ③ nucleic acid test within 12 hours before boarding, or nucleic acid within 24 hours before boarding + rapid antigen test within 12 hours → ④ Check in with blue code and negative report before boarding. The green codes obtained previously can continue to be used during the validity period.
The Chinese Embassy in South Korea emphasized that the above adjustments are arranged based on various factors such as the epidemic situation and the characteristics of virus mutation . Please continue to take personal protection before travel with a responsible attitude towards yourself and others, and consciously monitor your health (not filling in the form) to avoid positive tests before boarding and affecting your itinerary, or causing the epidemic to be imported after entering the country. If the local epidemic situation and imported cases from South Korea to China have rebounded significantly, relevant testing requirements may be adjusted dynamically.
(Editor: Zhao Xiaowen)
China Release